These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction. Hou ZQ; Sun ZX; Su CY; Tan H; Zhong X; Hu B; Zhou Y; Shang DY Cardiovasc Ther; 2013 Apr; 31(2):108-14. PubMed ID: 23490237 [TBL] [Abstract][Full Text] [Related]
44. The vasoactive-inotropic score and levosimendan: time for LVIS? Favia I; Vitale V; Ricci Z J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):e15-6. PubMed ID: 23507021 [No Abstract] [Full Text] [Related]
45. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial. Follath F Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368 [TBL] [Abstract][Full Text] [Related]
46. Levosimendan. Mason P Intensive Crit Care Nurs; 2003 Dec; 19(6):370-1. PubMed ID: 14637297 [No Abstract] [Full Text] [Related]
48. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure. Parissis JT; Adamopoulos S; Farmakis D; Filippatos G; Paraskevaidis I; Panou F; Iliodromitis E; Kremastinos DT Heart; 2006 Dec; 92(12):1768-72. PubMed ID: 17105880 [TBL] [Abstract][Full Text] [Related]
49. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure. Kivikko M; Antila S; Eha J; Lehtonen L; Pentikäinen PJ J Clin Pharmacol; 2002 Jan; 42(1):43-51. PubMed ID: 11808823 [TBL] [Abstract][Full Text] [Related]
50. [Application of levosimendan in acute heart failure patients with symptoms of low cardiac output: case series report]. Biegus J; Zymliński R; Kulej K; Szachniewicz J; Banasiak W; Jankowska EA; Ponikowski P Kardiol Pol; 2013; 71(3):275-8. PubMed ID: 23575784 [TBL] [Abstract][Full Text] [Related]
58. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. Nieminen MS; Akkila J; Hasenfuss G; Kleber FX; Lehtonen LA; Mitrovic V; Nyquist O; Remme WJ J Am Coll Cardiol; 2000 Nov; 36(6):1903-12. PubMed ID: 11092663 [TBL] [Abstract][Full Text] [Related]
59. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure]. Wang L; Cui L; Wei JP; Li GP; Qi GX; Hao YM; Wang WZ; Li HM; Liu J; Jiang DJ; Zhang YD Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):527-30. PubMed ID: 21033135 [TBL] [Abstract][Full Text] [Related]